Print

Lay Description

To investigate the efficacy, safety and tolerability of BI 409306 once daily compared to placebo given for 52 weeks to subjects with attenuated psychosis syndrome.

Category

  • Aging and Geriatric
  • Genetics
IRB Number
20180639HU
NCT Number
NCT # not yet entered

Eligibility

Eligible Ages
Between 16 Years and 30 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact


Floyd Jones
210-450-3158
jonesfa@uthscsa.edu

Amy Saklad
210-567-8229
saklada@uthscsa.edu

Mary Woolsey
210-567-8049
woolseym@uthscsa.edu